Cargando…
The long noncoding RNA ANRIL acts as an oncogene and contributes to paclitaxel resistance of lung adenocarcinoma A549 cells
Long non-coding RNAs (lncRNAs) are a family of non-protein-coding RNAs that might affect Lung adenocarcinoma (LAD) chemo-resistance and most of them could be used as biomarkers and therapy targets. However, the potential function of lncRNA ANRIL contributed paclitaxel chemo-resistance in LAD is stil...
Autores principales: | Xu, Ran, Mao, Yuqiang, Chen, Kuanbing, He, Wei, Shi, Wenjun, Han, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503604/ https://www.ncbi.nlm.nih.gov/pubmed/28402932 http://dx.doi.org/10.18632/oncotarget.16640 |
Ejemplares similares
-
Long Noncoding RNA ANRIL Promotes Cervical Cancer Development by Acting as a Sponge of miR-186
por: Zhang, Jun-Jun, et al.
Publicado: (2018) -
Prognostic Value of Plasma Long Noncoding RNA ANRIL for In-Stent Restenosis
por: Wang, Fang, et al.
Publicado: (2017) -
Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016) -
An increase in a long noncoding RNA ANRIL in peripheral plasma is an indicator of stable angina
por: Jiao, Yunjuan, et al.
Publicado: (2023) -
Four long noncoding RNAs act as biomarkers in lung adenocarcinoma
por: Zhang, Zhihui, et al.
Publicado: (2021)